-
Signature
-
/s/ David Baker, attorney-in-fact
-
Issuer symbol
-
GRI
-
Transactions as of
-
14 May 2021
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
18 May 2021, 16:08:07 UTC
Quoteable Key Fact
"Ofir Levi filed Form 4 for Vallon Pharmaceuticals, Inc. (GRI) on 18 May 2021."
Quick Takeaways
- This page summarizes Ofir Levi's Form 4 filing for Vallon Pharmaceuticals, Inc. (GRI).
- 2 reported transactions and 2 derivative rows are listed below.
- Filing timestamp: 18 May 2021, 16:08.
What Changed
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
GRI |
Stock Option (Right to Buy) |
Award |
$0 |
+15,000 |
|
$0.000000 |
15,000 |
14 May 2021 |
Common Stock |
15,000 |
$3.66 |
Direct |
F1 |
| transaction |
GRI |
Stock Option (Right to Buy) |
Award |
$0 |
+30,000 |
|
$0.000000 |
30,000 |
14 May 2021 |
Common Stock |
30,000 |
$3.66 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: